SEARCH

SEARCH BY CITATION

References

  • 1
    Qian, Y., Qin, J., Cui, G., Naramura, M., Snow, E. C., Ware, C. F., Fairchild, R. L. et al., Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 2004. 21: 575587.
  • 2
    Giltiay, N. V., Lu, Y., Allman, D., Jorgensen, T. N. and Li, X., The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation. J. Immunol. 2010. 185: 99109.
  • 3
    Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J. and Browning, J. L., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 1999. 190: 16971710.
  • 4
    Mehling, A., Loser, K., Varga, G., Metze, D., Luger, T. A., Schwarz, T., Grabbe, S. and Beissert, S., Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 2001. 194: 615628.
  • 5
    Higuchi, T., Aiba, Y., Nomura, T., Matsuda, J., Mochida, K., Suzuki, M., Kikutani, H. et al., Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J. Immunol. 2002. 168: 912.
  • 6
    Mackay, F., Silveira, P. A. and Brink, R., B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr. Opin. Immunol. 2007. 19: 327336.
  • 7
    Rauch, M., Tussiwand, R., Bosco, N. and Rolink, A. G., Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS One 2009. 4: e5456.
  • 8
    Qian, Y., Giltiay, N., Xiao, J., Wang, Y., Tian, J., Han, S., Scott, M. et al., Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren's syndrome. Eur. J. Immunol. 2008. 38: 22192228.
  • 9
    Li, X., Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine 2008. 41: 105113.
  • 10
    Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N. et al., The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994. 1: 167178.
  • 11
    Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Elsemore, J. et al., Mice deficient for the CD40 ligand. Immunity 1994. 1: 423431.
  • 12
    Elgueta, R., Benson, M. J., de Vries, V., Wasiuk, A., Guo, Y. and Noelle, R. J., Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 2009. 229: 152172.
  • 13
    Wen, L., Roberts, S. J., Viney, J. L., Wong, F. S., Mallick, C., Findly, R. C., Peng, Q. et al., Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells. Nature 1994. 369: 654658.
  • 14
    Dianda, L., Gulbranson-Judge, A., Pao, W., Hayday, A. C., Maclennan, I. C. and Owen, M. J., Germinal center formation in mice lacking alpha beta T cells. Eur. J. Immunol. 1996. 26: 16031607.
  • 15
    Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W. et al., TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000. 404: 995999.
  • 16
    Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P. and Cerutti, A., DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 2002. 3: 822829.
  • 17
    Groom, J. R., Fletcher, C. A., Walters, S. N., Grey, S. T., Watt, S. V., Sweet, M. J., Smyth, M. J. et al., BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J.Exp.Med. 2007. 204: 19591971.
  • 18
    He, B., Santamaria, R., Xu, W., Cols, M., Chen, K., Puga, I., Shan, M. et al., The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat.Immunol. 2010. 11: 836845.
  • 19
    Balazs, M., Martin, F., Zhou, T. and Kearney, J., Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity. 2002. 17: 341352.
  • 20
    Chang, N. H., Cheung, Y. H., Loh, C., Pau, E., Roy, V., Cai, Y. C. and Wither, J., B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice. PLoS One 2010. 5: e11691.
  • 21
    Kotzin, B. L. and West, S. G., Systemic Lupus Erythrematosus. In Rich, R., Shearer, W. T., Kotzin, B. L. and Schroeder Jr, H. W. (Eds.), Clinical immunology, principles and practice. Mosby International Limited, London, St. Louis, 2001, pp. 60.160.24.
  • 22
    Batten, M., Fletcher, C., Ng, L. G., Groom, J., Wheway, J., Laabi, Y., Xin, X. et al., TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J. Immunol. 2004. 172: 812822.
  • 23
    Bygrave, A. E., Rose, K. L., Cortes-Hernandez, J., Warren, J., Rigby, R. J., Cook, H. T., Walport, M. J. et al., Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2004. 2: e243.
  • 24
    Loder, F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C. and Carsetti, R., B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 1999. 190: 7589.
  • 25
    Batten, M., Groom, J., Cachero, T. G., Qian, F., Schneider, P., Tschopp, J., Browning, J. L. and Mackay, F., BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 2000. 192: 14531466.
  • 26
    Morimoto, S., Nakano, S., Watanabe, T., Tamayama, Y., Mitsuo, A., Nakiri, Y., Suzuki, J. et al., Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Rheumatology (Oxford) 2007. 46: 10831086.
  • 27
    Lavie, F., Miceli-Richard, C., Ittah, M., Sellam, J., Gottenberg, J. E. and Mariette, X., B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjogren's syndrome. Scand. J. Immunol. 2008. 67: 185192.
  • 28
    Tsao, P. Y., Jiao, J., Ji, M. Q., Cohen, P. L. and Eisenberg, R. A., T cell-independent spontaneous loss of tolerance by anti-double-stranded DNA B cells in C57BL/6 mice. J. Immunol. 2008. 181: 77707777.
  • 29
    Chen, X., Martin, F., Forbush, K. A., Perlmutter, R. M. and Kearney, J. F., Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 1997. 9: 2741.
  • 30
    Grimaldi, C. M., Michael, D. J. and Diamond, B., Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 2001. 167: 18861890.
  • 31
    Li, Y., Li, H. and Weigert, M., Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 2002. 195: 181188.
  • 32
    Merrell, K. T., Benschop, R. J., Gauld, S. B., Aviszus, K., cote-Ricardo, D., Wysocki, L. J. and Cambier, J. C., Identification of anergic B cells within a wild-type repertoire. Immunity 2006. 25: 953962.
  • 33
    Ota, M., Duong, B. H., Torkamani, A., Doyle, C. M., Gavin, A. L., Ota, T. and Nemazee, D., Regulation of the B cell receptor repertoire and self-reactivity by BAFF. J. Immunol. 2010. 185: 41284136.
  • 34
    Cariappa, A., Liou, H. C., Horwitz, B. H. and Pillai, S., Nuclear factor kappa B is required for the development of marginal zone B lymphocytes. J. Exp. Med. 2000. 192: 11751182.
  • 35
    Batten, M., Groom, J., Cachero, T. G., Qian, F., Schneider, P., Tschopp, J., Browning, J. L., and Mackay, F., BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 2000. 192: 14531466.
  • 36
    Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulga-Morskaya, S., Dobles, M., Frew, E. et al., An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001. 293: 21112114.
  • 37
    Doreau, A., Belot, A., Bastid, J., Riche, B., Trescol-Biemont, M. C., Ranchin, B., Fabien, N. et al., Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 2009. 10: 778785.
  • 38
    Jorgensen, T. N., Roper, E., Thurman, J. M., Marrack, P. and Kotzin, B. L., Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. Genes Immun. 2007. 8: 653662.